QSC PHARMA GRADE
🇮🇳 India Warehouse100-Count Pack
What is Zexipag 200mg (PAZOPANIB)?
Multi-kinase inhibitor for advanced renal cell carcinoma and advanced soft tissue sarcoma after prior chemotherapy.
How it Works
Inhibits VEGFR-1, -2, -3, PDGFR-alpha and -beta, and KIT — blocks tumor angiogenesis and proliferative signaling.
Quick Specs
| Form | Oral tablets — pre-dosed |
| Active Ingredient | PAZOPANIB |
| Dose per Tablet | 200MG |
| Pack Size | 10×10 (100 tablets) |
| Storage | Room temperature (15–25°C), cool dry place |
| Shelf Life | 2–3 years (properly stored) |
Common Side Effects
Hypertension (very common), hepatotoxicity, diarrhea, hair color changes (depigmentation), nausea, fatigue, QT prolongation.
Safety Warnings
⚠️ Hepatotoxicity monitoring mandatory — LFTs at baseline, then 4-8 weekly. Blood pressure monitoring from day 1. Antihypertensive treatment often required. QT prolongation monitoring.
Shipping: 🇮🇳 India Warehouse — international delivery
